Whalesbook
Laila Nutraceuticals Launches Women's Health Initiative at WEF Davos
Laila Nutraceuticals, a global entity specializing in botanical research and nutraceutical development, has introduced a new initiative dedicated to women's wellness. The announcement was made at the World Economic Forum (WEF) in Davos, marking a significant step towards advancing preventive and life-stage-aligned healthcare for women. The initiative is spearheaded by Yuthika Gokaraju, Vice President – Business Development at Laila Nutraceuticals. The program aims to address existing gaps in women's healthcare by providing solutions grounded in scientific validation and long-term impact.
Science-Backed Platform Fueled by Investment
The new initiative represents a strategic development drawing upon Laila Nutraceuticals' extensive history of scientific work in botanical research, spanning nearly five decades. The company is injecting approximately ₹350 crore to bolster its manufacturing capabilities in support of this expansion. This platform integrates traditional Indian botanical knowledge with contemporary clinical science, utilizing patented bioactives and advanced delivery systems to ensure efficacy and consistent absorption. The company's research infrastructure includes over 150 scientists and more than 20 patented ingredients. Laila Nutraceuticals operates cGMP-compliant manufacturing facilities and holds partnerships across 25 countries, underscoring its global operational footprint.
Addressing Key Women's Health Needs
The comprehensive platform is designed to support women across various stages of life. Its focus areas encompass reproductive and menstrual health, hormonal transitions, metabolic balance, bone and joint wellness, cognitive function, mood regulation, and healthy aging. This approach aligns with the growing global and national emphasis on preventive healthcare and the integration of traditional medicine, a sentiment echoed by Prime Minister Narendra Modi regarding the advancement of traditional medicine through scientific rigor and regulation.
Regulatory Alignment and Broader Context
The initiative is slated for a proposed co-launch under the regulatory guidance of the Food Safety and Standards Authority of India (FSSAI) and the Ministry of AYUSH. This collaboration reflects India's commitment to promoting evidence-based traditional and preventive healthcare systems. Former Union Minister Smriti Irani, who has been a proponent of women's empowerment, congratulated Yuthika Gokaraju on the launch, emphasizing the economic and public health importance of investing in women's well-being and highlighting India's growing capabilities in this sector. The broader nutraceutical market is witnessing increased attention towards women's health, with a growing demand for specialized, clinically validated solutions tailored to women's unique physiological needs throughout their lives.
Laila Nutraceuticals' Global Presence and Expertise
With a history of innovation, Laila Nutraceuticals has developed numerous patented ingredients and formulations, including those focused on brain health and metabolic disorders. The company functions as a Contract Development and Manufacturing Organization (CDMO), offering end-to-end services for nutraceutical brands globally, adhering to cGMP and FSSAI standards. Its global reach is evident through its export activities to markets such as the United States, Bangladesh, and Brazil.